Hosted on MSN8mon
GSK shares drag the FTSE 100 as company faces muli-billion pound bill after Zantac trial rulingThe FTSE 100 group won the case ... Citi analyst Peter Verdult pegged the bill at between $2bn (£1.6bn) and $3bn (£2.4bn). Redburn Atlantic has said the litigation “will settle for a figure ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback